Buying pressure lifts Canopy Growth higher in today trading

Traders Union
All News
Financial News
Canopy Growth rises 2.20% today

Highlights

Canopy Growth secured shareholder approval from MTL Cannabis for its $125 million cash-and-shares acquisition of Montreal-based MTL Cannabis, strengthening its industry position.
No additional corporate actions have been reported following the acquisition approval, underscoring the significance of this deal in Canopy's current strategic agenda.
Technically, Canopy Growth (CGC) trades at $1.20, near daily highs, but faces resistance at $1.23 and weak directional strength implies a higher probability of downside toward $1.09–$1.11.

Shareholder approval bolsters Canopy's acquisition-driven sector positioning

Canopy Growth has received shareholder approval from MTL Cannabis for its proposed acquisition deal, whereby Canopy will acquire Montreal-based MTL Cannabis for approximately $125 million in cash and shares. This acquisition is intended to enhance Canopy's position within the cannabis sector. No further corporate actions have been reported beyond this development.

Anton Kharitonov, expert at Traders Union, views Canopy Growth's momentum as fragile despite the short-term price bounce. He notes that current levels remain stuck below important moving averages, with mixed momentum signals and overbought indicators flashing caution. Kharitonov emphasizes that underlying bearish pressure is not alleviated by the MTL acquisition news, given the limited probability of further price gains and downside risk toward $1.09 if support at $1.15 fails. He observes a lack of strong trend strength, and warns that sentiment remains fragile. "Investors should remain vigilant here — any break below $1.15 could quickly accelerate selling, so risk management is critical at this stage."

Viktoras Karapetjanc, expert at Traders Union, believes the MTL Cannabis acquisition is a major step forward for Canopy Growth. He sees constructive potential in the deal, which reinforces the company's strategic positioning within the cannabis sector. Karapetjanc notes that recent technical resistance may limit upside, but the bullish structure remains intact as corporate developments unlock new opportunities. "This market offers multiple setups — I expect further growth as Canopy's expansion narrative gains momentum."

Jainam Mehta, market strategist, sees CGC trading in a tight volatility band with signals for both sides. He highlights a possible tactical setup: if resistance at $1.23 is breached, a short-term breakout could follow. Mehta cautions that the neutral ADX and mixed oscillators warrant a scenario-based approach. "Traders may consider a contrarian entry if the price consolidates above $1.15 while waiting for momentum confirmation."

Overbought oscillators contrast with mixed momentum and neutral trend signals

The nearest dynamic support is situated around the Ichimoku Kijun at $1.15, while resistance lies close to the MA-50 at $1.23. Momentum signals are mixed — MACD suggests strong daily sell pressure and ADX indicates a neutral trend with weak directional strength. Stoch RSI and CCI both show overbought conditions, while the RSI reads moderately bullish at 53.00. Intraday indicators point to buyer dominance according to Bull Power (BBP), but the Awesome Oscillator offers no active uptrend confirmation, and overall volatility remains moderate as prices approach session highs.

Previously it was reported that Canopy Growth Corporation demonstrated short-term bullish momentum above its 20-day moving average, encountering resistance near the 50-day average and Ichimoku Kijun, while remaining below the longer-term 200-day average. Momentum indicators including MACD, ADX, RSI, and overbought oscillators signal mixed sentiment and warn of possible overextension, as dilution risks from the MTL acquisition weigh on the outlook despite recent intraday strength.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.